Random mutagenesis of the nucleotide‐binding domain of NRC1 (NB‐LRR Required for Hypersensitive Response‐Associated Cell Death‐1), a downstream signalling nucleotide‐binding, leucine‐rich repeat (NB‐LRR) protein, identifies gain‐of‐function mutations in the nucleotide‐binding pocket. Issue 1 (26th May 2015)

• Record Type: Journal Article
• Authors: Sueldo, Daniela J.; Shimels, Mahdere; Spiridon, Laurentiu N.; Caldararu, Octav; Petrescu, Andrei‐Jose; Joosten, Matthieu H. A. J.; Tameling, Wladimir I. L.
• Is Part Of: New phytologist. Volume 208:Issue 1(2015:Oct. 01)
• Page Start: 210
• Page End: 223
• Publication Date: 2015-05-26
• Subjects: Botany -- Periodicals; 580
• DOI: 10.1111/nph.13459
• Languages: English
• ISSNs: 0028-646X

Abstract

<abstract abstract-type="main" id="nph13459-abs-0001"> <title>Summary</title> <p> <list id="nph13459-list-0001" list-type="bullet"> <list-item> <p>Plant nucleotide‐binding, leucine‐rich repeat (NB‐LRR) proteins confer immunity to pathogens possessing the corresponding avirulence proteins. Activation of NB‐LRR proteins is often associated with induction of the hypersensitive response (HR), a form of programmed cell death.</p> </list-item> <list-item> <p>NRC1 (NB‐LRR Required for HR‐Associated Cell Death‐1) is a tomato (<italic>Solanum lycopersicum</italic>) NB‐LRR protein that participates in the signalling cascade leading to resistance to the pathogens <italic>Cladosporium fulvum</italic> and <italic>Verticillium dahliae</italic>.</p> </list-item> <list-item> <p>To identify mutations in NRC1 that cause increased signalling activity, we generated a random library of NRC1 variants mutated in their nucleotide‐binding domain and screened them for the ability to induce an elicitor‐independent HR in <italic>Nicotiana tabacum</italic>. Screening of 1920 clones retrieved 11 gain‐of‐function mutants, with 10 of them caused by a single amino acid substitution.</p> </list-item> <list-item> <p>All substitutions are located in or very close to highly conserved motifs within the nucleotide‐binding domain, suggesting modulation of the signalling activity of NRC1. Three‐dimensional modelling of the nucleotide‐binding domain of NRC1 revealed that the targeted residues are centred around the bound nucleotide. Our mutational approach has generated a wide set of novel gain‐of‐function mutations in NRC1 and provides insight into how the activity of this NB‐LRR is regulated.</p> </list-item> </list> </p> </abstract>